With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA rejection after mysterious delay
With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA [...]
With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA [...]
Girding for BMS competition, Amgen wins another plaque psoriasis nod [...]
Eli Lilly finds embarrassment main cause of underreporting of symptoms [...]
GlaxoSmithKline reveals health fears of eosinophilic asthma patients, frustration of [...]
Boehringer’s ‘Breathless Ballad’ sees ‘American Idol’ winner Sparks lend lyrical [...]
Novavax’s COVID-19 vaccine scores WHO emergency listing, opening up supply [...]
Judge knocks back Purdue Pharma’s $4.5B bankruptcy settlement kdunleavy Fri, [...]
Biogen vows to contest EMA rejection of Aduhelm as EU [...]
Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T [...]
Inozyme rebrand shows the biopharma in a fresher, purple light [...]